Stroke Trial, Recruiting NCT07068620 Sponsor: University Hospital, Bordeaux Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07068620
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently enrolled in, or were previously enrolled in, the SHIVA cohort study
  • People who have basic computer skills, such as being able to open a web browser and use a mouse and keyboard
  • People who have access to a personal computer with an internet connection
  • People who are largely independent in everyday activities, as measured by standard daily living and instrumental daily living scales (confirm with trial site for exact score requirements)
  • People who have read, understood, and signed a written consent form, also signed by the investigating doctor

Who may not be able to join:

  • People with physical difficulties in their hands or arms that prevent them from using a keyboard and mouse (for example, severe hand joint disease)
  • People showing signs of depression based on a short screening questionnaire used in the trial (confirm with trial site for exact scoring details)
  • People who have age-related macular degeneration (a condition affecting central vision)
  • People with untreated glaucoma (a condition affecting eye pressure and vision)
  • People with untreated psychiatric conditions that interfere with cognitive testing
  • People with a diagnosed attention deficit disorder, with or without hyperactivity, or those who were unable to complete all cognitive tests required in the SHIVA cohort
  • People with ongoing conditions affecting the whole body that are known to cause cognitive changes, such as obesity or metabolic disorders
  • People with a history of epilepsy or seizures
  • People with scalp sensitivity or skin conditions such as dermatitis or open wounds on the scalp
  • People who have surgical clips, metal sutures, staples, stents, or bone fixation hardware in the head or neck
  • People with a pacemaker or any implanted neurostimulator device
  • People with an implanted hearing aid
  • People with metal fragments in or around the eyes, such as shrapnel or bullets
  • People who work with metal in a way that may have caused metal fragments to enter the body (confirm with trial site)
  • People with a heart valve or other implanted vascular material
  • People with a ventricular shunt valve (a device implanted in the brain to drain fluid)
  • People who have undergone brain stimulation treatment (such as tDCS or TMS) within the last 6 months
  • People who are currently taking part in another clinical trial or cognitive training program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0556795313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 August 2025
Est. completion
7 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

EEG signal power

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov